Literature DB >> 11117788

Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.

B P Rubin1, M R Pins, G P Nielsen, S Rosen, B L Hsi, J A Fletcher, A A Renshaw.   

Abstract

Wilms' tumors affecting adults are rare and are thought to have a worse prognosis than similar stage tumors in the pediatric population. To understand these tumors better, the authors reviewed their multi-institutional experience in a series of nine lesions diagnosed as Wilms' tumors in adults. In addition to histologic and immunohistochemical examination, they performed cytogenetic analysis and fluorescence in situ hybridization. On review, four cases were reclassified: two "blastema only" as Ewing's sarcoma/primitive neuroectodermal tumor and the other two as clear cell sarcoma of soft parts and sarcoma not otherwise specified (NOS). Of the remaining five cases, three exhibited biphasic histology and two were triphasic. In this group, there were three women and two men, and patient age ranged from 17 to 37 years (median age, 26 years). Tumor size was large and ranged from 10 to 31 cm (median tumor size, 12.5 cm). Histologically, the tumors showed the typical features of Wilms' tumors with varying amounts of blastema (n = 5), epithelium (n = 5), and stroma (n = 2). No tumors contained anaplasia, and persistent renal blastema was not identified in the non-neoplastic kidney in any specimen. All tumors were positive for cytokeratins (CK7, n = 3; pankeratin, n = 5), and one tumor was weakly positive for CD99 (0-13). Molecular analysis including dual color fluorescence in situ hybridization (all tumors), and cytogenetic analysis (n = 2) disclosed the presence of isochromosome 7q in three of five tumors whereas all tumors were diploid with respect to chromosome 12. Follow-up data ranged from 6 to 133 months (median follow-up, 82 months) with progression in only one patient who had stage IV disease with lymph node and lung metastases at presentation. The authors conclude that adult Wilms' tumor has been overdiagnosed. Most "blastema-only" tumors in adults are not Wilms' tumors, and in an adult, biphasic morphology should be the minimum criteria for their diagnosis. Using strict diagnostic criteria, adult Wilms' tumors have a relatively favorable prognosis. The characteristic findings of isochromosome 7q, lack of trisomy or tetrasomy for chromosome 12, and absence of persistent renal blastema suggest that the pathogenesis of Wilms' tumors in adults may be different than in the pediatric population. These genetic features may be helpful in distinguishing adult Wilms' tumors from other primary renal tumors.

Entities:  

Mesh:

Year:  2000        PMID: 11117788     DOI: 10.1097/00000478-200012000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors.

Authors:  Jenny Karlsson; Linda Holmquist Mengelbier; Peter Elfving; David Gisselsson Nord
Journal:  Virchows Arch       Date:  2011-09-23       Impact factor: 4.064

Review 2.  Neonatal tumours.

Authors:  Kokila Lakhoo; Helen Sowerbutts
Journal:  Pediatr Surg Int       Date:  2010-10-19       Impact factor: 1.827

3.  Primary primitive neuroectodermal tumor of the kidney: a case report.

Authors:  Suna Erkiliç; Coşkun Ozsaraç; N Emrah Koçer; Ahmet Erbağci
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.

Authors:  Pedram Argani; Satish K Tickoo; Andres Matoso; Christine A Pratilas; Rohit Mehra; Maria Tretiakova; Mathilde Sibony; Alan K Meeker; Ming-Tseh Lin; Victor E Reuter; Jonathan I Epstein; Jeffrey Gagan; Doreen N Palsgrove
Journal:  Am J Surg Pathol       Date:  2022-02-21       Impact factor: 6.298

5.  Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.

Authors:  Kimberly R Blish; Kathryn A Clausen; Gregory A Hawkins; A Julian Garvin; Mark C Willingham; Julie C Turner; Frank M Torti; Suzy V Torti
Journal:  J Exp Clin Cancer Res       Date:  2010-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.